169 related articles for article (PubMed ID: 26674651)
1. Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.
Goffinet C
Curr HIV Res; 2016; 14(3):211-6. PubMed ID: 26674651
[TBL] [Abstract][Full Text] [Related]
2. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
[TBL] [Abstract][Full Text] [Related]
3. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
[TBL] [Abstract][Full Text] [Related]
4. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.
Marziali F; Delpeuch M; Kumar A; Appourchaux R; Dufloo J; Tartour K; Etienne L; Cimarelli A
J Virol; 2021 Aug; 95(18):e0043921. PubMed ID: 34160255
[TBL] [Abstract][Full Text] [Related]
5. 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
Lodermeyer V; Suhr K; Schrott N; Kolbe C; Stürzel CM; Krnavek D; Münch J; Dietz C; Waldmann T; Kirchhoff F; Goffinet C
Retrovirology; 2013 Oct; 10():111. PubMed ID: 24156545
[TBL] [Abstract][Full Text] [Related]
6. M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.
Wang Q; Zhang X; Han Y; Wang X; Gao G
Sci Rep; 2016 Sep; 6():32736. PubMed ID: 27604950
[TBL] [Abstract][Full Text] [Related]
7. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
Colomer-Lluch M; Ruiz A; Moris A; Prado JG
Front Immunol; 2018; 9():2876. PubMed ID: 30574147
[TBL] [Abstract][Full Text] [Related]
8. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
[TBL] [Abstract][Full Text] [Related]
9. Apobec3G-Based Strategies to Defeat HIV Infection.
Ran X; Ao Z; Yao X
Curr HIV Res; 2016; 14(3):217-24. PubMed ID: 26957196
[TBL] [Abstract][Full Text] [Related]
10. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Tartour K; Appourchaux R; Gaillard J; Nguyen XN; Durand S; Turpin J; Beaumont E; Roch E; Berger G; Mahieux R; Brand D; Roingeard P; Cimarelli A
Retrovirology; 2014 Nov; 11():103. PubMed ID: 25422070
[TBL] [Abstract][Full Text] [Related]
11. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Tartour K; Nguyen XN; Appourchaux R; Assil S; Barateau V; Bloyet LM; Burlaud Gaillard J; Confort MP; Escudero-Perez B; Gruffat H; Hong SS; Moroso M; Reynard O; Reynard S; Decembre E; Ftaich N; Rossi A; Wu N; Arnaud F; Baize S; Dreux M; Gerlier D; Paranhos-Baccala G; Volchkov V; Roingeard P; Cimarelli A
PLoS Pathog; 2017 Sep; 13(9):e1006610. PubMed ID: 28957419
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle.
Colomer-Lluch M; Gollahon LS; Serra-Moreno R
Curr HIV Res; 2016; 14(3):175-82. PubMed ID: 26957194
[TBL] [Abstract][Full Text] [Related]
13. Dodging the Host Interferon-Stimulated Gene Mediated Innate Immunity by HIV-1: A Brief Update on Intrinsic Mechanisms and Counter-Mechanisms.
Chintala K; Mohareer K; Banerjee S
Front Immunol; 2021; 12():716927. PubMed ID: 34394123
[TBL] [Abstract][Full Text] [Related]
14. Same same but different - Antiviral factors interfering with the infectivity of HIV particles.
Kriesel F; Schelle L; Baldauf HM
Microbes Infect; 2020 Oct; 22(9):416-422. PubMed ID: 32450247
[TBL] [Abstract][Full Text] [Related]
15. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.
Bogerd HP; Kennedy EM; Whisnant AW; Cullen BR
mBio; 2017 Jan; 8(1):. PubMed ID: 28096489
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Xie M; Xuan B; Shan J; Pan D; Sun Y; Shan Z; Zhang J; Yu D; Li B; Qian Z
J Virol; 2015 Mar; 89(6):3049-61. PubMed ID: 25552713
[TBL] [Abstract][Full Text] [Related]
17. Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review.
Suo S; Ren X
Crit Rev Microbiol; 2016; 42(1):75-82. PubMed ID: 25811941
[TBL] [Abstract][Full Text] [Related]
18. The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?
Schaller T; Herold N
Curr HIV Res; 2016; 14(3):183-210. PubMed ID: 26957195
[TBL] [Abstract][Full Text] [Related]
19. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
20. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]